| CAF | Cancer-associated fibroblast |
| CAM | Cell adhesion molecule |
| Cath-E | Cathepsin-E |
| CA19.9 | Carbohydrate antigen 19.9 |
| CDCP1 CUB | domain-containing protein1 |
| Ce-CT | Contrast-enhanced Computed Tomography |
| CEA | Carcinoembryonic antigen |
| EGFR | Epidermoid growth factor receptor |
| EpCAM | Epithelial cell adhesion molecule |
| ESMO | European Society of Medical Oncology |
| FAP | Fibroblast-activating protein |
| FAPI | Fibroblast-activating protein inhibitor |
| FAZA | Fluoroazomycin arabinoside |
| FDG | Fluorodeoxyglucose |
| FGS | Fluorescence-guided surgery |
| FLT | Fluorothymidine |
| FMISO | Fluoromisonidazole |
| GRP78 | Glucose-regulating protein-78 |
| LAPC | Locally-advanced pancreatic cancer |
| mAb | Monoclonal antibody |
| MMP | Matrix metalloproteinase |
| MRI | Magnetic resonance imaging |
| NCCN | National Comprehensive Cancer Network |
| NET | Neuro endocrine tumor |
| NIR | Near infrared |
| NIRF | Near infrared fluorescence |
| NPT | Normal pancreatic tissue |
| NT | Neoadjuvant therapy |
| NTS | Neurotensin |
| NTSR-1 | Neurotensin receptor-1 |
| OS | Overall survival |
| PDAC | Pancreatic ductal adenocarcinoma |
| PSMA | Prostate membrane antigen |
| PET | Positron emission tomography |
| scFv | Single-chain variable fragment |
| SPECT | Single-photon emission computed tomography |
| SMI | Small molecule inhibitor |
| SUV | Standardized uptake value |
| TfR1 | Transferrin receptor-1 |
| TBR | Tumor-to-background ratio |
| TF | Tissue Factor |
| uPA | Urokinase-type plasminogen activator |
| uPAR | Urokinase-type plasminogen activator Receptor |
| VEGFR | Vascular endothelial growth factor receptor |
| VEGF-A | Vascular endothelial growth factor A |
| WLI | White light inspection |